South Korea-Based UNDBIO Plans Morgantown, West Virginia, Insulin Manufacturing Complex
04/20/2023
The company secured a lease with West Virginia University and will work to receive FDA approval for the product.
"The mission of UNDBIO is to develop and produce state-of-the-art insulin in West Virginia,” UNDBIO Chairman Caleb Jun said. “Our products will save human lives and improve the quality of life for those afflicted with diabetes. We are excited to see West Virginia become a mecca for manufacturing highly advanced insulin to treat diabetic patients around the world."
UNDBIO is the only Korean pharmaceutical company to provide a complete Diabetes care Solution by offering high-quality affordable Insulin, Insulin Analogs to meet the unmet need of diabetes patients.
“I join the Governor in expressing my excitement for this announcement today,” Secretary of the West Virginia Department of Commerce Mitch Carmichael noted. “This announcement, this company, this investment, and the potential for so many jobs for our hardworking West Virginians makes for a very great day. Good things are on the horizon, this is just the beginning!”
Project Announcements
Walmart Plans Upgrades Cullman, Alabama, Regional Distribution Hub
06/08/2023
Silver Branch Brewing Establishes Fauquier County, Virginia, Operations
06/08/2023
Protego (USA) Expands North Charleston, South Carolina, Operations
06/08/2023
South Korea-Based INFAC North America Expands Campbellsville, Kentucky, Operations
06/08/2023
Applied Physics Technologies Expands McMinnville, Oregon, Operations
06/02/2023
Bosch Expands Lincolnton, North Carolina, Operations
06/02/2023
Most Read
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
Is a Flurry of Fads Shaping Economic Development Policy?
Q2 2023
-
EV and Semiconductor Projects Stand Out in States Receiving Area Development’s 18th Annual Shovel Awards
Q2 2023
-
Life Science Conversions in Real Estate
Q2 2023
-
Front Line: Water Supply Increasingly Affecting Location Decisions
Q2 2023
-
Nearshoring — North America’s Next Factory
Q2 2023
-
First Person: Labor Crunch in the Construction Industry
Q2 2023